| Literature DB >> 18784102 |
Zoubida Karim1, Bénédicte Gérard, Naziha Bakouh, Rohia Alili, Christine Leroy, Laurent Beck, Caroline Silve, Gabrielle Planelles, Pablo Urena-Torres, Bernard Grandchamp, Gérard Friedlander, Dominique Prié.
Abstract
Impaired renal phosphate reabsorption, as measured by dividing the tubular maximal reabsorption of phosphate by the glomerular filtration rate (TmP/GFR), increases the risks of nephrolithiasis and bone demineralization. Data from animal models suggest that sodium-hydrogen exchanger regulatory factor 1 (NHERF1) controls renal phosphate transport. We sequenced the NHERF1 gene in 158 patients, 94 of whom had either nephrolithiasis or bone demineralization. We identified three distinct mutations in seven patients with a low TmP/GFR value. No patients with normal TmP/GFR values had mutations. The mutants expressed in cultured renal cells increased the generation of cyclic AMP (cAMP) by parathyroid hormone (PTH) and inhibited phosphate transport. These NHERF1 mutations suggest a previously unrecognized cause of renal phosphate loss in humans. 2008 Massachusetts Medical SocietyEntities:
Mesh:
Substances:
Year: 2008 PMID: 18784102 DOI: 10.1056/NEJMoa0802836
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245